Karin Hehenberger
Founder & CEO @ LyfeBulb
New York, United States
Karin Hehenberger is a Series A investor at LyfeBulb in New York focused on Medical and Biopharma. Karin Hehenberger is the Founder & Chief Executive Officer at Lyfebulb. She has also attended Harvard Medical School in 1998.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Karin Hehenberger invests in
Stages Karin Hehenberger invests in
Countries Karin Hehenberger invests in
Investment Focus
Industry
- Medical 1 (100%)
- Biopharma 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
AnaCardio
|
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure. | $14M / Series A / Sep 07, 2022 |
Co-Investors
About LyfeBulb
LyfeBulb Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Karin Hehenberger
Founder & CEO
|
|||
Stephen Squinto
Chairman
|
|||
Anthony Y. Sun
Advisory Board
|
|||
Lisa Hehenberger
Advisory Board
|
|||
Riccardo Braglia
Executive Board
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Karin Hehenberger invest in?
Karin Hehenberger invests primarily in Medical and Biopharma startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Karin Hehenberger last invest?
The most recent investment recorded for Karin Hehenberger closed in Sep 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
